• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device hydrogel spacer
Regulation Description Absorbable perirectal spacer.
Definition The perirectal spacer is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the perirectal spacer to reduce the radiation dose delivered to the anterior rectum. The perirectal spacer is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient’s body over time.
Product CodeOVB
Regulation Number 892.5725
Device Class 2


Premarket Reviews
ManufacturerDecision
BIOPROTECT, LTD.
  SUBSTANTIALLY EQUIVALENT 1
BOSTON SCIENTIFIC CORPORATION
  SUBSTANTIALLY EQUIVALENT 1
PALETTE LIFE SCIENCES
  SUBSTANTIALLY EQUIVALENT 1

MDR Year MDR Reports MDR Events
2020 126 126
2021 272 272
2022 387 387
2023 327 327
2024 329 329
2025 312 312

Device Problems MDRs with this Device Problem Events in those MDRs
Positioning Problem 1256 1256
Adverse Event Without Identified Device or Use Problem 348 348
Migration 48 48
Material Integrity Problem 43 43
Obstruction of Flow 38 38
Defective Device 32 32
Malposition of Device 31 31
Device Contamination with Chemical or Other Material 21 21
Inadequacy of Device Shape and/or Size 16 16
Use of Device Problem 15 15
Appropriate Term/Code Not Available 13 13
Material Deformation 8 8
Patient Device Interaction Problem 7 7
Contamination 4 4
Activation, Positioning or Separation Problem 3 3
Unsealed Device Packaging 3 3
Device-Device Incompatibility 2 2
Device Ingredient or Reagent Problem 2 2
Break 2 2
Positioning Failure 2 2
Device Dislodged or Dislocated 2 2
Connection Problem 2 2
Loose or Intermittent Connection 2 2
Fluid/Blood Leak 2 2
Leak/Splash 1 1
Device Contaminated During Manufacture or Shipping 1 1
Off-Label Use 1 1
Insufficient Information 1 1
Deflation Problem 1 1
Precipitate in Device or Device Ingredient 1 1
Packaging Problem 1 1
Product Quality Problem 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Clinical Signs, Symptoms or Conditions 822 822
Pain 356 356
Discomfort 205 205
Abscess 153 153
Fistula 143 143
Inflammation 127 127
Hemorrhage/Bleeding 125 125
Fluid Discharge 124 124
Ulcer 115 115
Unspecified Infection 101 101
Urinary Retention 87 87
Constipation 83 83
Fever 66 66
Perforation 58 58
Insufficient Information 52 52
No Consequences Or Impact To Patient 48 48
Swelling/ Edema 46 46
Hypersensitivity/Allergic reaction 39 39
Diarrhea 37 37
Urinary Frequency 29 29
Dysuria 27 27
Unspecified Kidney or Urinary Problem 21 21
Cramp(s) /Muscle Spasm(s) 21 21
Necrosis 20 20
Micturition Urgency 18 18
Embolism/Embolus 17 17
Urinary Tract Infection 17 17
Erosion 16 16
Loss of consciousness 16 16
Syncope/Fainting 16 16
Obstruction/Occlusion 15 15
Hematuria 15 15
Hematoma 15 15
Chills 14 14
Nausea 13 13
Low Blood Pressure/ Hypotension 13 13
Burning Sensation 13 13
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available 13 13
Rash 13 13
Skin Inflammation/ Irritation 12 12
Cardiac Arrest 11 11
Purulent Discharge 11 11
Unspecified Tissue Injury 11 11
Abdominal Pain 11 11
Fecal Incontinence 10 10
Bacterial Infection 10 10
Vomiting 10 10
Sepsis 10 10
Dizziness 9 9
Itching Sensation 9 9

Recalls
Manufacturer Recall Class Date Posted
1 Boston Scientific Corporation II Apr-25-2022
-
-